The Centers for Medicare & Medicaid Services (CMS) anticipated problems transitioning drug coverage for dual eligible beneficiaries from Medicaid to Medicare when Medicare Part D was implemented in 2006. This report examines the administrative efficiency of the "Point-of-Sale Facilitated...

Researchers interviewed oncology social workers and nurse practitioners in an effort to understand how the Medicare Part D doughnut hole affects beneficiaries’ financial access to oral anticancer targeted therapies. The findings highlight the financial obstacles associated with the Part D...

New data, prepared for the Centers for Medicare & Medicaid Services, provide detailed state-by-state and national information on prescription drug cost and utilization in 2003 for Medicaid beneficiaries enrolled in both Medicaid and Medicare (“dual eligiblesâ€), whose drug coverage...

This report presents findings from the Medicare Part D late enrollment penalty demonstration, which encouraged enrollment in Part D among low-income beneficiaries by eliminating the penalty for certain Medicare beneficiaries in the low-income subsidy program and those living in areas affected by...

Using 2007 pharmacy claims for postmenopausal Medicare beneficiaries with osteoporosis, this study found medication discontinuation and out-of-pocket drug costs were highest for those enrolled in Medicare Part D plans with a coverage gap.

This issue brief highlights a number of Medicaid prescription drug issues that remain for states after the movement of dual eligibles into the Medicare Part D drug benefit. The brief describes new data, prepared by Mathematica and available on the Centers for Medicare & Medicaid Services...

Using 2007 pharmacy claims for postmenopausal Medicare beneficiaries with osteoporosis, this study found medication discontinuation and out-of-pocket drug costs were highest for those enrolled in Medicare Part D plans with a coverage gap.